Belzutifan (Welireg™) for von Hippel Lindau disease

Belzutifan (brand name Welireg™) is a small-molecule drug with the molecular formula C17H12F3NO4S. The molecule consists of a fluorobenzonitrile moiety conjugated via an ether linkage to a bicyclic moiety that is modified by fluoridation, hydroxylation, and a methylsulfonyl group.